A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
Clinical trial NCT03583697 · COMPLETED
Trial details
- NCT number
- NCT03583697
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-13
- Primary completion
- 2022-01-26
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.